Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.36 |
| ▸ | GPR88 | Q9GZN0 | 4/20 | 0.35 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | AGXT | P21549 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL308112 | 0.94 | ERN1 (0.41) | ERN1PTGS2TSHRHRH3GPR88 | |
| SCHEMBL13681239 | 0.89 | ERN1 (0.38) | ERN1PTGS2TSHRHRH3GPR88 | |
| SCHEMBL15849135 | 0.89 | ERN1 (0.38) | ERN1PTGS2TSHRHRH3GPR88 | |
| SCHEMBL279311 | 0.89 | ERN1 (0.38) | ERN1PTGS2TSHRHRH3GPR88 | |
| SCHEMBL10105416 | 0.89 | ERN1 (0.38) | ERN1PTGS2TSHRHRH3GPR88 | |
| SCHEMBL13164336 | 0.88 | PTGS2 (0.36) | ERN1PTGS2TSHRHRH3GPR88 | |
| SCHEMBL279357 | 0.88 | APP (0.37) | ERN1PTGS2TSHRIDO1AGXT | |
| SCHEMBL10330363 | 0.87 | IDO1 (0.46) | ERN1PTGS2GPR88IDO1AGXT | |
| SCHEMBL279197 | 0.87 | IDO1 (0.50) | ERN1TSHRGPR88IDO1AGXT | |
| SCHEMBL279055 | 0.87 | AGXT (0.44) | ERN1PTGS2TSHRHRH3AGXT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394495-B2 | Composite structured organic films | XEROX CORPORATION (US) | 2013-03-12 | — | — | US | disclosed |
| US-8093347-B2 | Structured organic films | XEROX CORPORATION (US) | 2012-01-10 | — | — | US | disclosed |
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
| US-20100227157-A1 | COMPOSITE STRUCTURED ORGANIC FILMS | XEROX CORPORATION (US) | 2010-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227998-A1 | STRUCTURED ORGANIC FILMS | VIM, PUF60, EPCAM | ERN1 3053/4885PTGS2 4151/4885TSHR 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.